Header Logo

Connection

Nathalie Cartier-Lacave to Enzyme Inhibitors

Back to Details
This is a "connection" page, showing publications Nathalie Cartier-Lacave has written about Enzyme Inhibitors.
Nathalie Cartier-Lacave
Connection Strength
0.414
Enzyme Inhibitors
  1. Djelti F, Braudeau J, Hudry E, Dhenain M, Varin J, Bi?che I, Marquer C, Chali F, Ayciriex S, Auzeil N, Alves S, Langui D, Potier MC, Laprevote O, Vidaud M, Duyckaerts C, Miles R, Aubourg P, Cartier N. CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease. Brain. 2015 Aug; 138(Pt 8):2383-98.
    View in: PubMed
    Score: 0.414
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.